Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
The Longevity Fund, established in 2011, is a venture capital firm based in the United States. The organization is dedicated to funding companies that are developing drug candidates specifically targeting age-related diseases. This focus aims to advance the field of longevity and improve the quality of life for individuals as they age.
Currently, The Longevity Fund operates with a clear mission to support the creation of the first approved longevity drugs. The firm emphasizes the importance of mission-oriented founders, particularly those with unconventional backgrounds, who are believed to have a higher likelihood of success in this emerging sector. The firm’s investment strategy is primarily concentrated in the biotech and healthcare sectors.
The Longevity Fund invests in companies that are pioneering drug development for age-related diseases. Their investment strategy encompasses pre-seed, seed, and Series A stages, focusing on the biotech and healthcare sectors within the United States. The firm’s investment thesis highlights the significance of mission-oriented founders, particularly those with unconventional backgrounds, as they are seen as more likely to succeed in this evolving field.
The organization anticipates three stages of development in the longevity sector: Pioneers (2013-2023), Dominant players (2023-2050), and Generic players (2050+). This structured approach reflects their commitment to supporting innovative solutions that can transform how individuals over 50 plan their lives.
Laura Deming - Founder. Laura has a background in biotechnology and has been recognized for her work in the longevity sector. She has a strong track record of identifying promising startups in this niche.
Alex Colville - General Partner. Alex brings extensive experience in venture capital and has been involved in several successful investments in the biotech and healthcare industries.
Founders interested in pitching to The Longevity Fund should submit their proposals through the firm’s website at longevity.vc. It is recommended to include a clear outline of the business model, the team’s background, and the specific problem being addressed in the longevity sector.
What types of companies does The Longevity Fund invest in?
The Longevity Fund focuses on companies that are developing drug candidates for age-related diseases, particularly in the biotech and healthcare sectors.
What stages of investment does The Longevity Fund participate in?
The firm invests at the pre-seed, seed, and Series A stages, targeting early-stage companies that align with their mission.
What is the investment thesis of The Longevity Fund?
The investment thesis emphasizes the importance of mission-oriented founders with unconventional backgrounds, who are believed to be more likely to succeed in the longevity sector.
How can founders pitch to The Longevity Fund?
Founders can pitch their ideas through the firm’s website at longevity.vc. It is advisable to highlight the mission-driven aspect of their projects and the potential impact on age-related diseases.
What makes The Longevity Fund different from other investors?
The Longevity Fund distinguishes itself by focusing specifically on the longevity sector and supporting founders with unconventional backgrounds, which they believe enhances the likelihood of success in this niche market.
What is the geographic focus of The Longevity Fund?
The firm primarily invests in companies based in the United States, concentrating on the biotech and healthcare sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.